Intellectual Property Magazine
Trial date set for Teva's patent infringement suit
United States
Sophie Roberts - Staff Reporter
Teva Pharmaceutical Industries said that its patent infringement lawsuit against companies that are trying to market a generic
version of its multiple sclerosis (MS) drug Copaxone will go to trial.